Said Cifuentes Maury
Postdotoral Researcher @Moffitt Cancer Center
Signup · Get unlimited contacts
WORK HISTORY
Postdotoral Researcher @Moffitt Cancer Center
Tampa, FL, US
Skilled professional with innovative experience in perfusion-based microfluidic system for 3D cultures, leading to the creation of a laser confocal-compatible high-throughput chemotactic device for metastatic models, including spheroids and organoids.• Led the design and optimization of a biodegradable 3D hydrogel scaffold engineered to support T cell expansion, focusing on structural integrity, and biocompatibility to mimic physiological environments and enhance translational potential in immunotherapy.• Actively contributing to a Merck-funded initiative focused on precision oncology by processing prostate-derived patient samples and developing a 3D in vitro model (\"patient avatar\"), designed to replicate tumor microenvironments for high-throughput drug screening and personalized therapeutic evaluation.
EDUCATION
Universidad del Atlántico
INGENIERO MECÁNICO, Ingeniería mecánica
University of Puerto Rico-Mayaguez
Doctor of Philosophy - PhD, Bioengineering
University of Puerto Rico-Mayaguez
Master's degree, Materials and Manufacturing
ABOUT SAID CIFUENTES MAURY
Bioengineer | 3D Disease Models & Drug Screening | Translational OncologyI’m a Ph.D. Bioengineer (Mechanical Engineering M.S.) specializing in bridging biomaterials, 3D cell models, and high-throughput drug discovery to advance cancer therapies. My work focuses on translating lab-scale innovations into scalable solutions for biologics and immunotherapy development.What I Bring:3D Oncology Models: Designed patient-derived tumor avatars (Merck-funded) and microfluidic chemotaxis platforms (Moffitt) to mimic metastasis and streamline drug screening.Biologics & Immunotherapy: Engineered 3D hydrogel scaffolds for T-cell expansion, optimizing tumor-microenvironment interactions for adoptive cell therapies.High-Content/Throughput Screening (HCS/HTS): Applied live-cell confocal imaging, 96 & 384-well assays, and automated analysis (ImageJ) to quantify drug mechanisms in spheroids/organoids.Scalable Cell Manufacturing: At CMaT, transitioned MSC cultures to microcarrier systems, boosting yield 10x while cutting costs 80%—key for therapeutic cell supply.Why It Matters:My dual expertise in mechanical engineering and bioengineering allows me to uniquely bridge device innovation with biological discovery - from designing confocal-compatible microfluidic platforms for high-content screening to engineering 3D hydrogels that recapitulate tumor microenvironments for more predictive drug testing.Let’s Connect if you’re passionate about precision oncology, biologics screening, or biomaterial-enabled therapies!
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.